MAPK3 and skin cancer: For instance, P2RY6 has been shown to promote skin cancer development by modulating MAPK/ERK1-mediated Hippo/YAP and Wnt/β-catenin signaling, and to enhance migration in lung and colon cancer via the Rho/ROCK pathway (87, 88).